A risk stratification model to predict chemotherapy benefit in medullary carcinoma of the breast: a population-based SEER database

Whether patients with medullary breast carcinoma (MBC) receive chemotherapy is controversial. Therefore, the aim of our study was to screen out patients with MBC who benefit from chemotherapy. We enrolled 618 consecutive patients with MBC from The Surveillance, Epidemiology, and End Results (SEER) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Heyan, Pu, Shengyu, Wang, Lizhao, Zhang, Huimin, Yan, Yu, He, Jianjun, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317966/
https://www.ncbi.nlm.nih.gov/pubmed/37400489
http://dx.doi.org/10.1038/s41598-023-37915-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317966/
https://www.ncbi.nlm.nih.gov/pubmed/37400489
http://dx.doi.org/10.1038/s41598-023-37915-2

Ejemplares similares